{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:36:14Z","timestamp":1788809774458,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272753"],"award-info":[{"award-number":["82272753"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021LZL002"],"award-info":[{"award-number":["ZR2021LZL002"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bethune Cancer Radiotherapy Translational Medicine Research Fund","award":["flzh202103"],"award-info":[{"award-number":["flzh202103"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-024-02506-6","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T16:02:47Z","timestamp":1726156967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and safety of MR-guided adaptive simultaneous integrated boost radiotherapy to primary lesions and positive lymph nodes in the neoadjuvant treatment of locally advanced rectal cancer: a randomized controlled phase III trial"],"prefix":"10.1186","volume":"19","author":[{"given":"Haohua","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyu","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"issue":"3","key":"2506_CR1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/BF00298532","volume":"10","author":"JL McCall","year":"1995","unstructured":"McCall JL, Cox MR, Wattchow DA. Analysis of local recurrence rates after surgery alone for rectal cancer. Int J Colorect Dis. 1995;10(3):126\u201332.","journal-title":"Int J Colorect Dis"},{"key":"2506_CR2","doi-asserted-by":"crossref","unstructured":"Bois Hd, Heim TA, Lund A. Tumor-draining lymph nodes: at the crossroads of metastasis and immunity. Sci Immunol 2021, 6(63).","DOI":"10.1126\/sciimmunol.abg3551"},{"issue":"1","key":"2506_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.prro.2020.08.004","volume":"11","author":"JY Wo","year":"2021","unstructured":"Wo JY, Anker CJ, Ashman JB, Bhadkamkar NA, Bradfield L, Chang DT, Dorth J, Garcia-Aguilar J, Goff D, Jacqmin D, et al. Radiation Therapy for rectal Cancer: executive summary of an ASTRO Clinical Practice Guideline. Practical Radiation Oncol. 2021;11(1):13\u201325.","journal-title":"Practical Radiation Oncol"},{"issue":"8","key":"2506_CR4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S1470-2045(15)00004-2","volume":"16","author":"J Garc\u00eda-Aguilar","year":"2015","unstructured":"Garc\u00eda-Aguilar J, Chow O, Smith DD, Marcet J, Cataldo P, Varma M, Kumar AS, Oommen S, Coutsoftides T, Hunt S, et al. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol. 2015;16(8):957\u201366.","journal-title":"Lancet Oncol"},{"issue":"4","key":"2506_CR5","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.ijrobp.2020.06.013","volume":"108","author":"AM Couwenberg","year":"2020","unstructured":"Couwenberg AM, Burbach JPM, Berbee M, Lacle MM, Arensman R, Raicu MG, Wessels FJ, Verdult J, Roodhart J, Reerink O, et al. Efficacy of dose-escalated chemoradiation on complete tumor response in patients with locally advanced rectal Cancer (RECTAL-BOOST): a phase 2 Randomized Controlled Trial. Int J Radiation Oncology*Biology*Physics. 2020;108(4):1008\u201318.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"key":"2506_CR6","doi-asserted-by":"crossref","unstructured":"K\u00f6nig L, J\u00e4kel C, von Knebel Doeberitz N, Kieser M, Eberle F, M\u00fcnter M, Debus J, Herfarth K. Glioblastoma radiotherapy using intensity modulated Radiotherapy (IMRT) or proton Radiotherapy\u2014GRIPS Trial (Glioblastoma Radiotherapy via IMRT or Proton BeamS): a study protocol for a multicenter, prospective, open-label, randomized, two-arm, phase III study. Radiat Oncol 2021, 16(1).","DOI":"10.1186\/s13014-021-01962-8"},{"key":"2506_CR7","unstructured":"Overgaard M, Overgaard J, Sell A. Dose-response relationship for radiation therapy of recurrent, residual, and primarily inoperable colorectal cancer. Radiother Oncol."},{"issue":"4","key":"2506_CR8","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0360-3016(99)00486-1","volume":"46","author":"M Mohiuddin","year":"2000","unstructured":"Mohiuddin M, Regine WF, John WJ, Hagihara PF, McGrath PC, Kenady DE, Marks G. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response. Int J Radiation Oncology*Biology*Physics. 2000;46(4):883\u20138.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"issue":"1","key":"2506_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2014.08.035","volume":"113","author":"JPM Burbach","year":"2014","unstructured":"Burbach JPM, den Harder AM, Intven M, van Vulpen M, Verkooijen HM, Reerink O. Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: a systematic review and meta-analysis. Radiother Oncol. 2014;113(1):1\u20139.","journal-title":"Radiother Oncol"},{"issue":"12","key":"2506_CR10","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1007\/s00268-019-05135-3","volume":"43","author":"Y Atef","year":"2019","unstructured":"Atef Y, Koedam TW, van Oostendorp SE, Bonjer HJ, Wijsmuller AR, Tuynman JB. Lateral pelvic lymph node metastases in rectal Cancer: a systematic review. World j surg. 2019;43(12):3198\u2013206.","journal-title":"World j surg"},{"issue":"6","key":"2506_CR11","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00432-018-2624-6","volume":"144","author":"S Choi","year":"2018","unstructured":"Choi S, Chang J, Yoon HI, Jang D, Kim N, Lim J, Min B, Huh H, Shin S, Ahn J, et al. Mapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist\u2019s perspective. J Cancer Res Clin Oncol. 2018;144(6):1119\u201328.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"15","key":"2506_CR12","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.3390\/cancers14153665","volume":"14","author":"A Garant","year":"2022","unstructured":"Garant A, Vasilevsky C-A, Boutros M, Khosrow-Khavar F, Kavan P, Diec H, Des Groseilliers S, Faria J, Ferland E, Pelsser V, et al. MORPHEUS Phase II\u2013III study: a pre-planned Interim Safety Analysis and preliminary results. Cancers. 2022;14(15):3665.","journal-title":"Cancers"},{"issue":"4","key":"2506_CR13","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S2468-1253(22)00392-2","volume":"8","author":"J-P Gerard","year":"2023","unstructured":"Gerard J-P, Barbet N, Schiappa R, Magn\u00e9 N, Martel I, Mineur L, Deberne M, Zilli T, Dhadda A, Myint AS. Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2\u2013cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial. Lancet Gastroenterol Hepatol. 2023;8(4):356\u201367.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"2506_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3322\/caac.21707","volume":"72","author":"WA Hall","year":"2021","unstructured":"Hall WA, Paulson E, Li XA, Erickson B, Schultz C, Tree A, Awan M, Low DA, McDonald BA, Salzillo T, et al. Magnetic resonance linear accelerator technology and adaptive radiation therapy: an overview for clinicians. CA Cancer J Clin. 2021;72(1):34\u201356.","journal-title":"CA Cancer J Clin"},{"issue":"31","key":"2506_CR15","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1200\/JCO.2016.67.6049","volume":"34","author":"J Lef\u00e8vre","year":"2016","unstructured":"Lef\u00e8vre J, Mineur L, Kotti S, Rullier E, Rouanet P, Chaisemartin Cd, Meunier B, Mehrdad J, Cotte E, Desram\u00e9 J, et al. Effect of interval (7 or 11 weeks) between neoadjuvant radiochemotherapy and surgery on complete pathologic response in rectal Cancer: a Multicenter, Randomized, Controlled Trial (GRECCAR-6). J Clin Oncol. 2016;34(31):3773\u201380.","journal-title":"J Clin Oncol"},{"issue":"5","key":"2506_CR16","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/SLA.0000000000003530","volume":"270","author":"J Lef\u00e8vre","year":"2019","unstructured":"Lef\u00e8vre J, Mineur L, Cachanado M, Denost Q, Rouanet P, Chaisemartin Cd, Meunier B, Mehrdad J, Cotte E, Desram\u00e9 J, et al. Does a longer Waiting Period after Neoadjuvant Radio-chemotherapy improve the Oncological prognosis of rectal Cancer? Three years\u2019 follow-up results of the Greccar-6 Randomized Multicenter Trial. Ann Surg. 2019;270(5):747\u201354.","journal-title":"Ann Surg"},{"issue":"8","key":"2506_CR17","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S1470-2045(15)00004-2","volume":"16","author":"J Garcia-Aguilar","year":"2015","unstructured":"Garcia-Aguilar J, Chow OS, Smith DD, Marcet JE, Cataldo PA, Varma MG, Kumar AS, Oommen S, Coutsoftides T, Hunt SR, et al. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol. 2015;16(8):957\u201366.","journal-title":"Lancet Oncol"},{"issue":"35","key":"2506_CR18","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1200\/JCO.2011.37.7176","volume":"29","author":"M Maas","year":"2011","unstructured":"Maas M, Beets-Tan R, Lambregts D, Lammering G, Nelemans P, Engelen S, Dam RVv, Jansen R, Sosef M, Leijtens J, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol. 2011;29(35):4633\u201340.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2506_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3393\/ac.2019.04.15.1","volume":"35","author":"R Yoo","year":"2019","unstructured":"Yoo R, Kim HJ. Organ preservation strategies after Neoadjuvant Chemoradiotherapy for locally advanced rectal Cancer. Ann Coloproctol. 2019;35(2):53\u201364.","journal-title":"Ann Coloproctol"},{"issue":"3suppl","key":"2506_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1200\/JCO.2021.39.3_suppl.12","volume":"39","author":"AS Myint","year":"2021","unstructured":"Myint AS, Thamphya B, Gerard J-P. Does non-TME surgery of rectal cancer compromise the chance of cure? Preliminary surgical salvage data from OPERA phase III randomized trial. J Clin Oncol. 2021;39(3suppl):12\u201312.","journal-title":"J Clin Oncol"},{"key":"2506_CR21","doi-asserted-by":"crossref","unstructured":"Chiloiro G, Cusumano D, Boldrini L, Romano A, Placidi L, Nardini M, Meldolesi E, Barbaro B, Coco C, Crucitti A et al. THUNDER 2: THeragnostic Utilities for neoplastic DisEases of the rectum by MRI guided radiotherapy. BMC Cancer 2022, 22(1).","DOI":"10.1186\/s12885-021-09158-9"},{"key":"2506_CR22","doi-asserted-by":"crossref","unstructured":"Liu W, Shi J, Li N, Wang X, Gao Y-h, Chi Y, Sun Y, Zhao Q, Zhu Y, Chen H-D et al. The safety of an MRI simulation-guided boost after short-course preoperative radiotherapy for unresectable rectal cancer (SUNRISE): interim analysis of a randomized phase II trial. Radiat Oncol 2022, 17(1).","DOI":"10.1186\/s13014-022-02182-4"},{"issue":"6","key":"2506_CR23","doi-asserted-by":"publisher","first-page":"e065010","DOI":"10.1136\/bmjopen-2022-065010","volume":"13","author":"M Verweij","year":"2023","unstructured":"Verweij M, Tanaka MD, Kensen C, Heide UAvd, Marijnen C, Janssen T, Vijlbrief T, Grevenstein WVv, Moons L, Koopman M, et al. Towards response ADAptive radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial. BMJ Open. 2023;13(6):e065010.","journal-title":"BMJ Open"},{"issue":"3","key":"2506_CR24","doi-asserted-by":"publisher","first-page":"e499","DOI":"10.1016\/j.clcc.2018.03.009","volume":"17","author":"AM Couwenberg","year":"2018","unstructured":"Couwenberg AM, Burbach JPM, van Grevenstein WMU, Smits AB, Consten ECJ, Schiphorst AHW, Wijffels NAT, Heikens JT, Intven MPW, Verkooijen HM. Effect of Neoadjuvant Therapy and rectal surgery on Health-related quality of life in patients with rectal Cancer during the first 2 years after diagnosis. Clin Colorectal Cancer. 2018;17(3):e499\u2013512.","journal-title":"Clin Colorectal Cancer"},{"issue":"9","key":"2506_CR25","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1200\/JCO.2005.05.256","volume":"23","author":"CAM Marijnen","year":"2005","unstructured":"Marijnen CAM, van de Velde CJH, Putter H, van den Brink M, Maas CP, Martijn H, Rutten HJ, Wiggers T, Kranenbarg EK, Leer J-WH, et al. Impact of short-term preoperative radiotherapy on Health-related quality of life and sexual functioning in primary rectal Cancer: report of a Multicenter Randomized Trial. J Clin Oncol. 2005;23(9):1847\u201358.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2506_CR26","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1016\/j.prro.2018.08.010","volume":"9","author":"N El-Bared","year":"2019","unstructured":"El-Bared N, Portelance L, Spieler BO, Kwon D, Padgett KR, Brown KM, Mellon EA. Dosimetric benefits and practical pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer. Practical Radiation Oncol. 2019;9(1):e46\u201354.","journal-title":"Practical Radiation Oncol"},{"issue":"3","key":"2506_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.radonc.2017.11.032","volume":"126","author":"L Henke","year":"2018","unstructured":"Henke L, Kashani R, Robinson C, Curcuru A, DeWees T, Bradley J, Green O, Michalski J, Mutic S, Parikh P, et al. Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen. Radiother Oncol. 2018;126(3):519\u201326.","journal-title":"Radiother Oncol"},{"issue":"2","key":"2506_CR28","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.prro.2020.09.005","volume":"11","author":"MD Chuong","year":"2021","unstructured":"Chuong MD, Bryant J, Mittauer KE, Hall M, Kotecha R, Alvarez D, Romaguera T, Rubens M, Adamson S, Godley A, et al. Ablative 5-Fraction stereotactic magnetic resonance\u2013guided Radiation Therapy with On-Table adaptive replanning and elective nodal irradiation for Inoperable Pancreas Cancer. Practical Radiation Oncol. 2021;11(2):134\u201347.","journal-title":"Practical Radiation Oncol"},{"issue":"4","key":"2506_CR29","doi-asserted-by":"publisher","first-page":"e049119","DOI":"10.1136\/bmjopen-2021-049119","volume":"12","author":"E Hudson","year":"2022","unstructured":"Hudson E, Noutch S, Brown S, Adapala R, Bach S, Burnett C, Burrage A, Gilbert A, Hawkins M, Howard D, et al. A phase II trial of higher RadiOtherapy Dose in the eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trial. BMJ Open. 2022;12(4):e049119.","journal-title":"BMJ Open"},{"key":"2506_CR30","doi-asserted-by":"crossref","unstructured":"Chiloiro G, Romano A, Cusumano D, Boldrini L, Panza G, Placidi L, Meldolesi E, Nardini M, Meffe G, Nicolini G et al. THeragnostic utilities for neoplastic DisEases of the rectum by MRI guided radiotherapy (THUNDER 2) phase II trial: interim safety analysis. Radiat Oncol 2023, 18(1).","DOI":"10.1186\/s13014-023-02353-x"},{"issue":"1","key":"2506_CR31","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.clon.2020.06.008","volume":"33","author":"N Hearn","year":"2021","unstructured":"Hearn N, Atwell D, Cahill K, Elks J, Vignarajah D, Lagopoulos J, Min M. Neoadjuvant Radiotherapy Dose Escalation in locally advanced rectal Cancer: a systematic review and Meta-analysis of Modern Treatment approaches and outcomes. Clin Oncol. 2021;33(1):e1\u201314.","journal-title":"Clin Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-024-02506-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-024-02506-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-024-02506-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T16:04:34Z","timestamp":1726157074000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-024-02506-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2506"],"URL":"https:\/\/doi.org\/10.1186\/s13014-024-02506-6","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"14 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the Affiliated Cancer Hospital of Shandong First Medical University approved the final protocol (Grant No. SDZLEC2023-390-02) in accordance with the Declaration of Helsinki and GCP principles. Formal approval is required for any change to the protocol that affects the conduct, patient benefit or safety of the trial. Patients will provide written informed consent after receiving a thorough explanation of the rationale, benefits and potential side effects. The trial will adhere to local regulations (clinicaltrail.gov identifier: NCT06246344).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}